[Centrally-acting antihypertensive drugs].
Takishita
Shuichi
S
Division of Cardiovascular Medicine, Nephrology and Neurology, University of Ryukyus School of Medicine.
Yamazato
Masanobu
M
D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003000:Clonidine / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D006143:Guanabenz / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D016316:Guanfacine / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D054755:Imidazoline Receptors; D007668:Kidney / Q000378:metabolism; D008750:Methyldopa / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D011311:Pressoreceptors / Q000503:physiopathology; D011955:Receptors, Drug / Q000819:agonists; D012079:Renal Circulation / Q000187:drug effects; D012964:Sodium / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D013565:Sympatholytics / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D014655:Vascular Resistance
D000959:Antihypertensive Agents; D054755:Imidazoline Receptors; D011955:Receptors, Drug; D013565:Sympatholytics; D016316:Guanfacine; D008750:Methyldopa; D012964:Sodium; D006143:Guanabenz; D003000:Clonidine; D009638:Norepinephrine